An MPL W515L mutation in refractory anemia with ringed sideroblasts associated with marked thrombocytosis: A case report

  • Authors:
    • Lin Hao
    • Sandeep Sen
    • Dhivya Sugumar
  • View Affiliations

  • Published online on: December 2, 2014     https://doi.org/10.3892/ol.2014.2754
  • Pages: 749-751
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The current study presents the case of a 63‑year‑old patient exhibiting refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS‑T), who was positive for the MPL W515L mutation, but negative for the JAK2 V617F mutation. Following diagnosis, the patient remained asymptomatic for over three years, however, in August 2012, the patient relapsed and was administered with supportive treatment in the form of subcutaneous darbepoetin α at a dose of 300 µg/week, which resulted in an increased hemoglobin concentration, allowing the patient to remain transfusion‑independent. The MPL W515L mutation has been reported in two previous cases of myelodysplastic/myeloproliferative neoplasms (MDS/MPN) with ringed sideroblasts, however, to the best of our knowledge, the current report is the first to present a case of RARS‑T with an MPL W515L mutation. A clinical trial designed to evaluate the efficacy of a targeted agent against the JAK2 V617F mutation is currently ongoing, with the aim of providing a novel therapeutic strategy for treating MDS/MPN patients. As MPL is located upstream of the JAK‑STAT signaling pathway, it is a possible therapeutic target in MDS/MPN patients positive for an MPL W515L mutation, but negative for a JAK2 V617F mutation.
View Figures
View References

Related Articles

Journal Cover

February-2015
Volume 9 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Hao L, Sen S and Sugumar D: An MPL W515L mutation in refractory anemia with ringed sideroblasts associated with marked thrombocytosis: A case report. Oncol Lett 9: 749-751, 2015
APA
Hao, L., Sen, S., & Sugumar, D. (2015). An MPL W515L mutation in refractory anemia with ringed sideroblasts associated with marked thrombocytosis: A case report. Oncology Letters, 9, 749-751. https://doi.org/10.3892/ol.2014.2754
MLA
Hao, L., Sen, S., Sugumar, D."An MPL W515L mutation in refractory anemia with ringed sideroblasts associated with marked thrombocytosis: A case report". Oncology Letters 9.2 (2015): 749-751.
Chicago
Hao, L., Sen, S., Sugumar, D."An MPL W515L mutation in refractory anemia with ringed sideroblasts associated with marked thrombocytosis: A case report". Oncology Letters 9, no. 2 (2015): 749-751. https://doi.org/10.3892/ol.2014.2754